Taylor, Graham P, Goon, Peter, Furukawa, Yoshitaka, Green, Hannah, Barfield, Anna, Mosley, Angelina, ...
Abstract Background No therapies have been proven to persistently improve the outcome of HTLV-I-associated myelopathy. Clinical benefit has been reported with zidovudine and with lamivudine in...
Jeffery, Katie J. M., Usuku, Koichiro, Hall, Sarah E., Matsumoto, Wataru, Taylor, Graham P., Procter, Jeanette, ...
The risk of disease associated with persistent virus infections such as HIV-I, hepatitis B and C, and human T-lymphotropic virus-I (HTLV-I) is strongly determined by the virus load. However, it is...
Saito, Mineki, Taylor, Graham P., Saito, Akiko, Furukawa, Yoshitaka, Usuku, Koichiro, Weber, Jonathan N., ...
Using HLA-peptide tetrameric complexes, we isolated human T-cell lymphotrophic virus type 1 Tax peptide-specific CD8+ T cells ex vivo. Antigen-specific amino acid motifs were identified in the T-cell...
Taylor, Graham P, Goon, Peter, Furukawa, Yoshitaka, Green, Hannah, Barfield, Anna, Mosley, Angelina, ...
Jeffery, Katie J. M., Usuku, Koichiro, Hall, Sarah E., Matsumoto, Wataru, Taylor, Graham P., Procter, Jeanette, ...
The risk of disease associated with persistent virus infections such as HIV-I, hepatitis B and C, and human T-lymphotropic virus-I (HTLV-I) is strongly determined by the virus load. However, it is...
Saito, Mineki, Taylor, Graham P., Saito, Akiko, Furukawa, Yoshitaka, Usuku, Koichiro, Weber, Jonathan N., ...
Using HLA-peptide tetrameric complexes, we isolated human T-cell lymphotrophic virus type 1 Tax peptide-specific CD8+ T cells ex vivo. Antigen-specific amino acid motifs were identified in the T-cell...